Source: Annual Congress 2001 - Novel approaches to treatment of lung disease
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. C. Chambellan, E. Maurellet, M. Tessier, E. Chailleux, P. Germaud (Nantes, France). Itraconazole and allergic bronchopulmonary aspergillosis: long-term follow-up. Eur Respir J 2001; 16: Suppl. 31, 2906

Member's Comments

No comment yet.

Related content which might interest you: Follow-up of patients with allergic bronchopulmonary aspergillosis (ABPA) - side effects of long-term therapy Source: Eur Respir J 2003; 22: Suppl. 45, 237s Year: 2003 Place of azoles in the treatment of allergic bronchopulmonary candidiasis Source: Eur Respir J 2006; 28: Suppl. 50, 52s Year: 2006 Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis Source: Eur Respir J 2014; 43: 1487-1500 Year: 2014 Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease? Source: Eur Respir Rev 2010 19: 261-263 Year: 2010 Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA). Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations Source: Eur Respir Rev 2014; 23: 149-152 Year: 2014 Clinical presentation in 12 patients with allergic bronchopulmonary aspergillosis Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007 Living with allergic bronchopulmonary aspergillosis Source: Breathe, 15 (2) 108; 10.1183/20734735.0170-2019 Year: 2019 A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma Source: Eur Respir J, 52 (3) 1801159; 10.1183/13993003.01159-2018 Year: 2018 Clinical characteristics and outcome of patients with allergic bronchopulmonary aspergillosis Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma Source: Eur Respir J 2016; 47: 490-498 Year: 2016 Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis Source: Eur Respir Rev 2010 19: 349-351 Year: 2010 Bronchodilator responsiveness in children with cystic fibrosis and allergic bronchopulmonary aspergillosis Source: Eur Respir J, 56 (2) 2000175; 10.1183/13993003.00175-2020 Year: 2020 Treating allergic bronchopulmonary aspergillosis: the way forward Source: Eur Respir J 2016; 47: 385-387 Year: 2016 Effect of itraconazole therapy on disease course in 3 cases of allergic bronchopulmonary mycosis presented as refractory asthma Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond Year: 2008 Omalizumab in patients with allergic bronchopulmonary aspergillosis (ABPA): a multicenter case series study in Spain Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 Airway remodelling easily develops in patients with allergic bronchopulmonary aspergillosis Source: Annual Congress 2009 - Airways remodelling Year: 2009 Effects and side effects of long term steroid therapy of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Long term follow up of the lung function in cystic fibrosis patients with allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Complex treatment of allergic bronchopulmonary aspergillosis (ABPA) in asthmatic patient including anti-IgE therapy – A case report Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012